Vincerx Pharma, Inc. (VINC) reported Q3 EPS of ($0.80), $0.25 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
Vincerx Pharma, Inc. (VINC) reported Q3 EPS of ($0.80), $0.25 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .